This inventor holds 1 USPTO granted patent. Top assignee: Oulun Yliopisto. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations by Tuomas Kenttä in Cardiac Risk Prediction
Introduction
Tuomas Kenttä is a notable inventor based in Kempele, Finland. He has made significant contributions to the field of cardiac health through his innovative patent. His work focuses on predicting the risk of cardiac death, which is crucial for early intervention and treatment.
Latest Patents
Kenttä holds a patent for an "Apparatus, method, and computer program for predicting risk for cardiac death." This invention involves detecting early repolarization patterns in electrocardiogram (ECG) leads. The method identifies if the amplitude of a J-point at the QRS complex and ST segment junction exceeds a predetermined threshold. Additionally, it assesses amplitude patterns of ST segments in the ECG leads. If early repolarization patterns are detected in at least two leads, and the ST segments show a horizontal or descending amplitude pattern, the system predicts an elevated risk for future cardiac death due to possible arrhythmia.
Career Highlights
Tuomas Kenttä is affiliated with Oulun Yliopisto, where he continues to advance research in cardiac health. His innovative approach combines technology and medical science, aiming to improve patient outcomes through early detection of cardiac risks.
Collaborations
Kenttä collaborates with esteemed colleagues such as Jani Tikkanen and Heikki Huikuri. Their combined expertise enhances the research and development of effective cardiac risk prediction methods.
Conclusion
Tuomas Kenttä's contributions to cardiac health through his innovative patent demonstrate the importance of technology in medicine. His work not only advances scientific knowledge but also has the potential to save lives through early detection and intervention.